See how naturally advanced automation can be used in the life sciences back office, regulatory compliance, clinical trial process, pharmacovigilance efforts, and more strategic applications of data and analytics.
Debates about market access in the specialty drug realm are heating up. This is especially true for products targeting indications with exceedingly high levels of medical need. These are the diseases we call “breakthrough innovation areas” since rapid advancements in the standard of care are either occurring or planned.
As U.S. healthcare providers start to come to terms with the realities of the shift towards pricing transparency, many provider executives- CFOs in particular- are now asking how they can 'get ahead' of pricing transparency in order to protect (and possibly even grow) net patient revenues.